Updated Oct 9, 2026 · 04:30 UTC
VRTXVertex Pharmaceuticals Incorporated
Health Care · United States · XNAS · pharmaceutical preparations
$503.87−0.47%last session · market closed
Market cap
$127.71b
real-world
Tokenized
$7k
<0.001% of the asset
Avg token price
$503.52
−0.07% vs real
Spot volume, 24h
—
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
VRTX · Price
Apr 28, 2025low $362.97 · high $559.00 · now $503.14Oct 8, 2026
Earnings
Nasdaq’s earnings calendar
Next earnings
Nov 2
estimated date · Sep 2026 quarter · EPS forecast $4.30 (6 analysts)
Last earnings, Aug 3
$4.20 EPS
+1.2% vs $4.15 forecast · Jun 2026 quarter
Real market
Vertex Pharmaceuticals Inc
Last close
$505.64
Oct 7
Traded on Oct 7
$408.9m
Price now
$503.87
market closed
Where it trades
24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · — · 0 venues
None yet
Derivatives · — · 0 venues
None yet
Onchain versions
2 tokens from 2 issuers
VRTXonOndo Assetstied here$503.52$7k
wVRTXxBacked Assets——By chain
Where the tokens circulate, issuers’ unsold stock taken off
In DeFi
Pools and lending markets that hold these tokens
None found
Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$12.59b
+10% YoY
Operating income
$4.78b
38% margin · +22% YoY
Net income
$4.41b
35% margin · +21% YoY
EPS, diluted
$17.26
+23% YoY
Cash and balance sheet
Free cash flow
$3.80b
30% of revenue
Cash and securities
$13.64b
debt not tagged
Diluted shares
255m
−1% YoY
Valuation at today’s market cap
P/E
29×
P/S
10.1×
Free cash flow yield
3.0%
Quarterly
RevenueNet income